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ABSTRACT
The study of evolutionary innovations, or novel traits, is integral to understanding
evolution yet is poorly understood. By studying the regions between genotype networks
that produce the same phenotype, we can better characterize the process by which
innovation occurs. The overarching goal of this study is to assign fitness values to the
overlapping genotype network of two catalytic RNA molecules, or ribozymes. Properly
characterizing this region requires the study of thousands of individual sequences, which
is achievable through the use of high-throughput sequencing analysis. This thesis focuses
on developing assays for one of the ribozymes, the ligase ribozyme. Due to the low
activity of this ribozyme, the best method for detection proved to be through qPCR
amplification and fluorescence detection. This method allows for troubleshooting before
sequencing, as well as validation afterward. It was adapted to create the sequencing assay
for the ligase ribozyme, which turned out to be comprehensive in its coverage of the
tested space, and reproducible between runs. Several ligase sequences were discovered
with higher activities than the previous best ligase ribozymes. In addition, the utilization
of phased primers proved to be very successful in increasing initial-read diversity in the
sequencing pool. The work developing assays for the ligase ribozyme successfully
contributed to the larger study on innovation.

Key words: ribozyme, fitness landscape, innovation, high-throughput sequencing,
RNA, genotype network, phenotype, evolutionary trajectory
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DEVELOPING ULTRA-HIGH THROUGHPUT SEQUENCING BASED ASSAY FOR
LIGASE RIBOZYMES FOR THE STUDY OF EVOLUTIONARY INNOVATIONS
1. Introduction
It is common to describe evolution as an optimization process where continuous
cycles of reproduction, mutation, and selection lead to the steady improvement of traits to
match specific environments. However, sometimes anomalies arise that are unlike
anything seen before. Occasionally, these anomalies can be classified as innovations –
qualitatively novel traits that enable organisms to inhabit completely new environments
(Moczek et al. 2011). The primary question of this thesis is not, “How are advantageous
traits selected for?” but, “How do new traits arise to begin with?” The mechanisms of the
evolution of innovation remain elusive to experimentation.
Innovation is easy to recognize, but difficult to define. Some definitions include
“any newly acquired structure or property that permits the assumption of a new function,”
(Mayr 1960) and “a qualitatively new structure with a discontinuous origin, marking a
relatively abrupt deviation from the ancestral condition” (Müller and Nitecki 1990). The
glowing light of a firefly and the eyespots on a moth’s wings are good examples of easily
recognizable innovations in nature. The line gets fuzzy when considering the narwhal’s
enlarged tooth or the protrusions on a Hercules beetles’ carapace (Moczek 2008). These
could be considered modifications of preexisting structures, and may not be an abrupt
enough deviation to be true innovation. When are they new structures, and when are they
just glorified old ones?
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In order to define novelty in biology, it is useful to explore the opposite yet more
familiar concept of homology. Two structures are homologous if they have a shared
genetic ancestry. The forelegs of beetles and flies are homologous to each other, and the
front, middle, and back legs are serially homologous, but these are obvious examples of
homology. In order to separate more ambiguous homologous traits from non-homologous
traits, additional insight must be gathered, such as from developmental biology (Shubin et
al. 2009). Looking at similarities between structures at different stages of an organism’s
development sheds light on which of these structures are homologous and which are not.
Another place to look is gene expression. If similar genes are expressed to produce
different structures, they are derived from a common gene and can be considered
homologous. By using these tools to determine what is homology, we can also determine
what is innovation.
The macroscopic novelties described above are generated by changes at the level
of genes and their protein and RNA products. For example, regulatory circuits can be a
tool that leads to innovation. Changes to macromolecular structures, such as transcription
factors or their DNA targets, can result in the upregulation of genes in certain tissues of
an organism. This can create novel structures, such as the eye spots on butterflies
(Monteiro 2015). In addition, new environmental challenges can be overcome by simply
mixing and matching elements currently present in the organism to produce a novel
metabolic network (Dantas et al. 2008). Many bacteria have been studied that have
created new pathways to utilize new carbon sources, or to break down hazardous
compounds, by reshuffling a metabolic pathway (Rehmann and Daugulis 2008). Finally,
even changes in simple macromolecules can produce significant innovations, such as
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antifreeze proteins that enable organisms to survive freezing (Fletcher et al. 2001). At the
core, each of these examples requires a different type of change at the genetic level,
which leads to innovation that is observable at larger, macroscopic scales.
For a discussion of genetic innovations, it is useful to define the concept of
genotype space. Each organism has a genotype, or a specific DNA genome. Changing
any DNA base in an organism’s genome can be thought of as a step in the space of all
possible DNA genomes, or genotype space. Many of these genotypes code for the same
phenotypes, or physical characteristics. Sometimes there are genetic steps that result in
new phenotypes. These are the regions of innovation (Figure 1). When selective pressures
are added, the fitness, or environmental viability, of each phenotype must also be taken
into account. The probability of a mutational path through genotype space toward a
specific innovation depends upon the fitness of each intermediate mutational change
(Bendixsen et al. 2018). Generally, in order to innovate, there must exist one or more
paths through genotype space from one phenotype to another, and the associated fitness
values along those paths must be high enough to survive the current environment.
Although at first glance it seems unlikely that both of these requirements could be
satisfied concurrently with any reasonable probability, the high dimensionality of
genotype space and the genotypic redundancy of most phenotypes make it plausible.
Genotype space contains a mesh of entwining phenotypes with many points of
contact, and these contact points enable innovation. Even a small gene that is only 150
nucleotides long has 2 x 1090 possible sequences, which is greater than the total number
of atoms in the known universe. Many of these genotypes share the same phenotype, and
not just those genotypes that are different by only a few mutations. Genotypes can often
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be more different than similar and still share the same phenotype, so each phenotype is
sprawled far across genotype space with many contact points to other phenotypes
(Wagner 2011). In other words, if a functional gene has many possible sequences, each of
those sequences (or more precisely, sequence clusters) has different neighboring genes
with different functions. Going back to our 150 nucleotide gene, each sequence in this
space has 149 neighbors, allowing for a nearly infinite number of trajectories, or
mutational pathways, from one sequence to another. This results in a vast, highly
connected web of genotypes with phenotypes that can span most of the space. The main
hinderance to nature’s exploration of this space is the fitness requirements of survival.
But as selection pressures relax or supporting structures such as chaperones evolve, lower
fitness genotypes can survive, opening more trajectories through this space for
exploration (Figure 2). When conditions relax, existing phenotypes gain contact points to
other phenotypes, enabling innovation.
In order to study innovation on a large scale, a model system is required in which
the fitness of numerous genotypes can be studied quickly and accurately. Catalytic RNA
molecules, or ribozymes, offer a tractable system with both genotype and phenotypes.
The genotype of RNA is defined as the order of nucleotides. Unlike DNA, RNA is
generally single stranded, and thus can fold and base pair intramolecularly. The
phenotype of RNA is defined as the structure resulting from these intramolecular
interaction, or the biochemical function of this structure. Ribozymes are typically small
RNA molecules that can be produced in large quantities through in-vitro transcription.
Their functions can often be visualized through simple laboratory methods such as gel
electrophoresis, qPCR, and next-generation sequencing, the last of which is the best tool
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available for exploring relatively large pieces of genotype space in high-throughput.
These effects can be measured relative to each other, resulting in a “fitness”
measurement. This ease of production, visualization, and comparison makes them
excellent models to study innovation, without the maintenance and maturation
requirements associated with studying living organisms. The study of ribozymes is
important for understanding their roles in Nature (Ren et al. 2017), and also as a tool in
biotechnology as gene regulators and reporter molecules (Lee et al. 2018). Thus,
ribozymes lend themselves to the study of innovation.
When studying innovation, the best approach is to explore the boundaries between
distinct phenotypes. In order to simplify the problem to a manageable project, we chose
two previously characterized Ribozyme phenotypes of similar genotypic length (Schultes
and Bartel 2000). The first was adapted from the self-cleaving ribozyme originally found
in the Hepatitis Delta Virus (Figure 3). The second is a modified version of the class III
ligase, a ribozyme artificially selected from a pool of random sequences. The HDV
phenotype cleaves a piece of itself near its 5’ end, while the Ligase phenotype ligates a
substrate RNA to itself. Although these functions are opposites, they require significantly
different folds, and have different origins. The landscape of active sequences for each
function come into close proximity. The goal of this research is to create as many
relevant sequences as possible near the intersection, test their activities, and utilize this
data to help characterize the boundaries of genetic innovation.
Studying the boundaries of innovation in vitro is novel and informative. Previous
research studying fitness landscapes of ribozymes has been limited by technology.
Researchers are forced either to limit the size of their ribozymes or their coverage of the
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landscape. Alternatively, computational models can give a theoretical idea of the space,
but are only useful insofar as they are accurate. As next-generation sequencing
technology improves, though, more of the space can be studied for larger ribozymes (Pitt
and Ferré-D’Amaré 2010; Jiménez et al. 2013). This high-throughput process allows
millions of sequences to be read in parallel, and with sufficient coverage of each
genotype, is able to detect low activity ribozymes accurately. Although these strategies
have been utilized before, exploring the space of innovation between two phenotypes is
novel and may reveal insight into how innovation occurs. This requires new assays that
can detect very low activity ribozymes accurately before sequencing. The objective of my
thesis research is to create these assays, develop the sequence library, and analyze the
resulting data, especially in regard to the ligase ribozyme.
2. Methods
2.1 Ribozyme synthesis by in vitro transcription
A ssDNA template library was ordered and diluted to 10 µM in TE8 buffer. The
template contained a 92 base region adapted from the class III ligase with 14 ambiguous
bases at specific locations. A non-interacting 30 base universal primer binding site was
added to the 3’ end of the template, and a T7 polymerase promoter sequence to the 5’
end. The promoter sequence was made double stranded by annealing 20 pmol of a T7
primer to 20 pmol of the template by heating to 98°C for 2 minutes and cooling to room
temperature. This template was transcribed to RNA using an Ambion Megashortscript
kit. Transcription reactions were incubated at 37C for 2h followed by a 20-minute
DNase treatment, also from Ambion. The resulting RNA was purified using a silicabased column (Zymo), then split into triplicate groups.
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2.2 Reaction and reverse transcription
500 pmol of a synthetic oligonucleotide substrate comprised of DNA except for
the last 9 bases on the 3’-end was reacted with approximately 400 pmol of purified RNA
for two hours at 37°C in a 10 mM magnesium and 80 µM Tris pH 7.5 buffer.
Approximately 100 pmol of RNA from the completed reaction was then reverse
transcribed at 42°C for 90 minutes using 20 pmol of the RT primer, which was
complimentary to the 3’-end of the RNA (Table 1). The resulting DNA was purified
using a silica-based column (Zymo).
2.3 Sequencing preparation
cDNA from reacted sequences was amplified in a PCR reaction using 10 pmol of
a primer specific to the substrate sequence (Table 1). Illumina specific adapter sequences
were added through PCR, then column purified and sent off for Illumina Nextseq 500
single-end 150 base sequencing at the University of Oregon. Both PCR reactions were
stopped just before saturation.
2.4 Analysis of activity
Counts of each variant were tallied from the sequencing data by parsing fastq data
using custom python scripts. The fraction reacted was calculated as the ratio of ligated
sequences to the total for each.
2.5 Activity measurement via qPCR
Prior to an HTS run, key individual sequences’ activities were measured via
qPCR. Starting with cDNA for an individual variant, primers specific to either the
substrate sequence or general to all sequences were used in a qPCR amplification.
Fraction reacted was calculated from the difference in Cq between ligated and total
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groups, after accounting for primer efficiency. Ligated primer Efficiency (LE), Ligated
ribozymes Cq (LCq), Unligated primer efficiency (UE), Unligated ribozymes Cq (UCq):
LELCq
UEUCq

3. Results and Discussion
3.1 Library Design
We needed to design a library of sequences that would be large enough to cover a
relevant portion of genotype space, while at the same time small enough to be analyzed
through high-throughput sequencing. Ideally, we would have liked to study the entire
genotype space between the wild-type HDV ribozyme and the original class III ligase
ribozyme. Unfortunately, we were limited by current high-throughput sequencing
technology, since a ribozyme of a hundred random bases contains 4100 or 1.6 x 1060
sequences, and current Illumina sequencing technology can read around 1.6 x 108
sequences per run. Since we were mainly concerned with the region of sequence space
near the intersection between the two functions, we rationally designed an endpoint
candidate for each phenotype by studying the base-pairing of the ribozymes and the
effects of previously studied individual mutations. These endpoints were separated by
fourteen mutations, which would guarantee that the entire library could be captured in a
single high-throughput sequencing run with sufficient coverage of each sequence. By
randomizing these mutational differences between the bases from each sequence, we
created a pool of 214 = 16,384 unique sequences. Since our ribozyme had ambiguous
regions near the ends, a primer binding site was required for reverse transcription, PCR
amplification, and the addition of Illumina primers. We used a self-interacting universal
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primer binding site that would not interact with the rest of the ribozyme (Wilkinson et al.
2006). Since ordered DNA oligonucleotides can contain ambiguous bases, we could
order our whole library in a single tube. Since current high-throughput sequencing
provided around 100 million reads, and our library contained 16,384 sequences, each
sequence had over 1,000 reads. Thus, by comparing sequencing runs measuring Ligase
and HDV activity separately, we were able to sample a large portion of genotype space
and study the region of innovation.
3.2 Ligase qPCR Assay allows low-activity detection
In order to test individual sequence activities, we developed a quantitative
polymerase chain reaction, or qPCR, assay. After failing to visualize the Ligase
ribozyme’s activity on a gel, we attempted to use substrate oligonucleotide sequence
modified with a fluorophore on the 5’ end. This allowed us confirm the presence of
ligated ribozymes, but did not allow quantification because the unligated RNA was not
detectable. Thus, we decided to try reverse transcribing and amplifying the ligated and
unligated fragments separately. Following end-point PCR, we were able to observe bands
on gel corresponding to the size expected for ligated and unligated ribozyme PCRproducts. This strategy turned out to be very successful, as can be seen by the easily
detectable difference in size between the ligated and unligated lanes in Figure 4. To
quantify the amount of each species, we proceeded to adapt the strategy to RT-qPCR to
verify ligation activity of many sequences concurrently with good accuracy.
In order to generalize this strategy to other ribozyme variants, though, a generic
reverse transcription adapter sequence was necessary. This way, rather than having to
order a different reverse transcription primer for every new ribozyme, a consistent primer

10
could be used. We tested a sequence previously reported to be non-interfering and selfinteracting, two traits we were looking for (Wilkinson et al. 2006). We found the
sequence to have negligible effect on ligation rate, with a log transformed relative
ligation of 6.7 compared to the original primer’s relative ligation of 5.8 (Figure 5a).
The final qPCR assay involved transcribing, ligating, and reverse transcribing
sequences of interest, then splitting the resulting DNA into two qPCR amplifications
performed using different sets of reverse primers. The first set attached inside the
ribozyme and amplified all ribozymes (Figure 6a). The second attached to the substrate
sequence of the ligase, and amplified only the ligated ribozymes (Figure 6b). Dividing
the ligated by the total yields the percent of ribozymes that ligated for the sequence in
question. For example, in Figure 7, the total RNA for the first construct (a) (13.7 Cq)
compared to the ligated RNA from (A) (20.1 Cq) yields a ratio of 0.0176, or 1.76%
ligation, after accounting for a primer efficiency of approximately 1.9 for both sets of
primers. Similarly, the second construct (b) (17.9 Cq) versus (B) (23.7 Cq) yields a ratio
of 0.0257, or 2.57% ligation.
One of the first applications of our qPCR assay was to test the effect of an extra
‘G’ base that was present at the beginning of the original Ligase sequence, but not the
HDV sequence. We wished to measure the effect of removing this base on Ligase
activity, as it would have been difficult to include in our sequence library. Using the
qPCR assay, we were able to determine that its effect was minor, since ligation rates with
and without the mutation were similar (Figure 5b). Thus, we were able to eliminate this
indel mutation entirely, and limit our library to strictly point-mutations. This reduced the
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number of library sequences we had to order, and made sequence alignment more
straightforward.
The qPCR assay allowed for proof of concept tests before the initial sequencing
run, as well as validation of the sequencing run by comparing activities from each
method. The substrate specific primer was also used in the actual high-throughput
sequencing run, with Illumina-specific adapters attached. A template switching
oligonucleotide was used during reverse transcription to add adapters to the pool of total
ribozymes, since one of the fourteen mutations blocked the non-specific primer. Thus, the
percent of ligated ribozymes could be calculated in a similar manner after sequencing.
3.3 Phased Primers
Phased primers dramatically improved clustering for our low-diversity library.
Since high-throughput sequencing distinguishes individual sequencing “clusters” based
on their differences early in the sequencing process, and in our initial sequencing run, our
sequences were all nearly identical at the start, the sequencer failed to distinguish
between neighboring clusters. It is possible to spike in random sequences to help
clustering, generally fragments from the PhiX genome, but this was not sufficient to
solve the problem. Thus, we developed phased primers with variations in the nucleotide
sequence and length, with the goal of creating easily distinguishable clusters for HTS to
progress (Table 1). These primers are identical except for a unique four base code that is
repeated a varying number of times, and created enough differences at the start of the
sequences for appropriate clusters to form. They also offset the rest of the ribozyme from
its neighbors, such that all calls after the primer was read were not the same either. In this
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way, we were able to use high-throughput sequencing, a tool designed mainly for
genomic sequencing, to sequence our ribozyme landscape.
3.4 All Sequences Detected with Tight Correlation Between Replicates
High-throughput sequencing provided over 100 million reads from our library,
from which we were able to find every sequence in our library in abundance. As expected
from previous studies on the ligase ribozyme, the reacted library contained large
discrepancies between the counts for each sequence. Most sequences contained between
20 and 200 reads, but the most abundant had over 20,000. Without proper
countermeasures, we could not assume that all these differences are due strictly to
variation in ligation rate. Our rNTP mix was an even 25% for each base, which could
perhaps favor the synthesis of sequences with a more even distribution of bases
throughout (Krieg and Melton 1987). In addition, the buffer and temperature conditions
could have favored synthesis of some sequences over others during transcription. To
account for these differences, however minor, we compared our reacted library to a
control library. By using the unreacted library as a baseline for differences in library
synthesis, we could determine the real ligation rates for each sequence. We could also
compare the data across the three replicates of each run, and across two sequencing runs.
The ligase data was very consistent, with any two replicate runs having a coefficient of
determination of 0.99 (Figure 8). Distinguishing between ribozymes with similar
activities depends on the error in our measurements, so the smaller the variance in the
fitness measurement, the better we can distinguish between RNA molecules with similar
fitness. This tight correlation also allows detection of lower abundance molecules, which
will allow us to expand our library size in the future.
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After sequencing, we plotted the fitness values of the ligase sequences using
Gephi (Figure 9). The right endpoint of the space is the ligase reference sequence, while
the left endpoint of the space is the HDV reference sequence. The x and y axes represent
sequence space, while the z axis represents fitness on a log scale. The high-activity ligase
sequences are highly skewed toward the ligase reference side of the space. Although less
than 1% of the total sequences have fitness values above the Ligase reference, many of
those that do are substantially more fit than the reference. Since this space has not been
explored before, this is potentially the first time these high-activity Ligase sequences
have been discovered. The results from the ligase sequencing were later combined with
the results from the HDV sequencing, resulting in a more comprehensive understanding
of the region of innovation, discussed fully in the appendix below.
4. Conclusion
This thesis research demonstrates a new high-throughput sequencing based assay
for the class III ligase ribozyme, in addition to the accessory assays leading up to
sequencing. Before the qPCR assay, detection of low activity ribozymes such as the
ligase ribozyme were difficult or impossible, as the resolution of a gel was often
insufficient. The assay enabled the testing and comparison of many individual sequence
variants, such that suitable endpoints for our library could be found. With endpoints, the
library could be ordered, including the necessary extremities. The transition from qPCR
preparation to sequencing preparation was reasonably straightforward. The sequencing
assay was highly reproducible, and enabled detection of a wide range of activities for
over 16,000 unique sequences simultaneously. After sequencing, the final analysis of the
data in conjunction with the HDV data provided many insights into the boundaries of
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innovation. Even focusing on the ligase data alone, many variants were found with
activities many times higher than the reference.
Although this research laid a solid foundation, there is still room for further study.
Other regions of sequence space could be explored by allowing the mutations to vary
among all four bases, or by choosing different mutations. Other types of mutations, such
as insertions and deletions, could be included. One could study different cleavase and
ligase molecules, or different catalytic reactions altogether. All of these alternatives
require more room in the next-generation sequencer. In order to squeeze as many
genotypes in as possible, the coverage of each genotype could be reduced by about tenfold without negatively impacting the resolution. With time, next-generation sequencing
will improve as well.
The work involving the ligase ribozyme was half of the necessary data to study
innovation. The other half involves the HDV ribozyme, and was conducted by Devin
Bendixsen. The Ligase activities reported in this thesis were combined with HDV selfcleaving activities. The results and discussion of this complete data set were prepared as a
separate manuscript, which has been included in this thesis in the appendix.
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Tables and Figures:
Table 1:

Important Sequences

RT primer

GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGAACCGGACCGAAGCCCG

Substrate oligo

AAGCATCTAAGCATCTCAAGCrArArArCrCrArGrUrC

Selective, phased

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG GCATGCATGCATGCATGC

sequencing primer 1

AAGCATCTAAGCATCTCAAGCAAACCAG

Selective, phased
sequencing primer 2

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG TGCATGCATGCATGC
AAGCATCTAAGCATCTCAAGCAAACCAG

Selective, phased
sequencing primer 3

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG ATGCATGCATGC
AAGCATCTAAGCATCTCAAGCAAACCAG

Selective, phased
sequencing primer 4

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG CATGCATGC
AAGCATCTAAGCATCTCAAGCAAACCAG

Non-selective qPCR

GAMTCCCATTAGRCTGG

Phased Template

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG GCATGCATGCATGCATGC

primer

Switching Oligo (TSO) 1

rGrGrG

Phased TSO 2

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG TGCATGCATGCATGC rGrGrG

Phased TSO 3

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG ATGCATGCATGC rGrGrG

Phased TSO 4

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG CATGCATGC rGrGrG

Figure 1.
Innovation and Genotype Space. Dots represent individual genotypes,
while colors represent phenotypes. The circled portion indicates a region of
innovation in which a transition occurs from one phenotype to another.
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Figure 2.
Genotype networks. Dots represent individual genotypes, while colors
represent phenotypes. a. Under strict conditions, only the fittest genotypes can
survive, leaving little room for exploration. b. When conditions relax, more genotypes
are accessible, opening trajectories from one phenotype to another.

Figure 3.
HDV and Ligase Ribozymes. The HDV ribozyme cleaves a portion of
RNA from its 5’ end, whereas the Ligase ribozyme ligates a substrate to its 5’ end.
The bases are color coded according to the base pairing of the HDV ribozyme to
demonstrate that no two regions are paired the same.
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Figure 4.
RT-PCR amplification of ligated ribozymes. This gel demonstrated the
viability of an RT-qPCR strategy for visualizing the low-activity ligase ribozyme’s
activity. Lane (a) contains the ladder, and (b)-(e) and (f)-(i) contain two variants of
the ligase ribozyme. (b) and (f) are the ligated bands, while (d) and (h) contain total
RNA (unligated and ligated RNA). (c) and (e) are the no-enzyme controls, while (g)
and (i) are the no-template controls for each group.

Figure 5.
qPCR Testing of Adapters and a Base Difference. Relative ligation
after background subtraction of our original adapter vs the non-interfering selfinteracting adapter (a), and of the ligase sequence with and without the initial ‘G’
base (b). Both graphs display similar ligation values, well within an order of
magnitude.
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Figure 6.
Detection of Ligase Activity. In order to detect ligase activity, two
reverse primers were used. In (a), a generic primer amplifies all ribozymes. In (b), a
substrate specific primer only amplifies ligated ribozymes.

Figure 7.
Quantification of Ligase Activity by qPCR. The plot shows DNA
fluorescence (y-axis) as a function of PCR cycle number (x-axis) for two different
ligase ribozyme constructs. This data was used to quantify the ligase activity of each
construct. The total RNA concentration of the first construct is given by the Cq value
(a), after taking into account the primer efficiency. The concentration of the ligated
product of this construct is given by the Cq value of (A). The same is true for (b) and
(B). The no-template negative control is (c).
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Figure 8.
Consistency of Ligase ribozyme frequencies in sequencing data from
replicate ligation reactions. Each data point represents a unique sequence in the
library. The axes are the log10 transformed number of reads for the indicated
replicate, with a distribution of the density of those reads on the opposite side.

Figure 9.
Ligase Fitness. The x and y axes represent sequence space, while the z
axis represents fitness. The Ligase reference ribozyme and its fitness is included.
Application of Assay:
The work developing assays and analysis for the ligase ribozyme is only a portion
of the project, which I focused on. This work was combined with Devin Bendixsen’s data
for the HDV cleavase ribozyme. Software for computer simulations in the analysis phase
were provided in part by a collaborator, Dr. Bjorn Ostman. The entire project was
overseen by Dr. Eric Hayden. The project can be found in the appendix below.
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Abstract:
Evolutionary innovations are qualitatively novel traits that emerge
through evolution and increase biodiversity. The genetic mechanisms of
innovation remain poorly understood. A systems view of innovation requires
the analysis of genotype networks – the vast networks of genetic variants that
produce the same phenotype. Innovations can occur at the intersection of two
different genotype networks. Here, we study the fitness landscape between the
genotype networks of two catalytic RNA molecules (ribozymes) by
determining the ability of numerous neighboring RNA sequences to catalyze
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two different chemical reactions. We find extensive functional overlap, and
over half the genotypes can catalyze both functions to some extent. We
demonstrate through evolutionary simulations that these numerous points of
intersection facilitate the discovery of a new function, yet the rate of
optimization depends upon the starting location in the genotype network. The
study reveals the properties of a fitness landscape where genotype networks
intersect, and the consequences for evolutionary innovations.
One Sentence Summary: Experimental fitness landscapes between two
genotype networks provide the direct observation of the evolution of a novel
function.
Main Text:
The mechanisms by which evolution produces new functions has intrigued
biologists since the earliest formulations of evolutionary theory (1, 2). Random genetic
changes and natural selection would seem to prevent novelty by keeping populations near
genotypes at the peaks of fitness landscapes, preserving existing forms at the expense of
novel mutants (3–5). Models to explain the origins of new functions often invoke gene
duplication events, which create redundancy needed to allow either copy to eventually
evolve toward a new function (6–9). However, the fitness landscape between old and new
functions has been difficult to study largely because of the vast number of possible genetic
variants for any given gene. As a result, models of innovation differ in the relative
importance of neutral drift, environmental changes, the timing and type of selection
pressure, and the high-dimensional nature of sequence space (10). Our understanding of
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innovations will benefit from direct observations of the evolution of new functions (11–
16).
Macromolecular phenotypes such as enzymes can tolerate changes to their primary
sequence without necessarily changing structure or function. As a consequence of this
robustness to mutations, many genotypes have the same phenotype (17, 18). Natural
populations of both organisms and macromolecules that appear the same phenotypically
still harbor many genetic differences. Genotype networks are the collection of all genotypes
with the same phenotype that are interconnected by mutational steps (19). Populations
occupy finite regions of these vast networks, and it has been suggested that innovations
can occur where two genotype networks are in close proximity (20) (Fig. 1A). To evaluate
various models of molecular innovation, it is necessary to characterize the number of
mutations that separate two networks and the fitness consequences of the mutational
changes needed to move from one network to the other.
Here, we report an experimentally constructed intersection of two genotype
networks. For our study system we have chosen two distinct RNA phenotypes. The RNA
molecules are ribozymes, structured RNA molecules that catalyze chemical reactions. One
ribozyme phenotype is the naturally-occurring self-cleaving HDV ribozyme. The second
phenotype is the class III ligase ribozyme that was discovered through artificial selection
in a lab (Fig. 1B) (21). The two ribozymes share no evolutionary history, catalyze different
chemical reactions, and fold into very different structures. Despite the differences between
the two ribozymes, it was previously shown that the two genotype networks come in close
proximity, and very few mutations could convert one ribozyme into the other (22). This
provides an experimentally tractable example of a molecular innovation. To characterize
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the fitness landscape between the two genotype networks we developed two highthroughput sequencing based assays to quantify both ribozyme phenotypes. We analyzed
16,384 neighboring sequence variants using both assays. For each sequence, we
determined the ribozyme fitness for both activities, defined as the catalytic activity relative
to a reference sequence. With these fitness values, we analyzed the billions of mutational
trajectories between the two genotype networks, and used computational simulations to
explore how these genotype networks facilitate or inhibit evolutionary innovations.
We obtained fitness measurements for all 16,384 RNA sequences for both RNA
phenotypes. For visualization of the resulting genotype networks, we plot the data as a
network graph, where each node is a unique sequence, nodes are connected if they differ
by a single mutation, and the fitness is represented by the size of the node (Fig. 2A). Each
node is colored based on the dominant activity, with HDV in red and Ligase in blue. Fitness
values were normalized such that fitness = 1 for the reference ribozyme, previously referred
to as the “prototype” (22). This representation of the data allows a visual appraisal of the
proximity of the two genotype networks. In general, both networks are characterized by a
decrease in fitness with distance from the reference. The region where the two networks
are in closest proximity contains sequences with low activity for either function. Still, we
find that numerous genotypes in the two networks are proximal, and numerous distance
measurements are required to characterize the mutational distance between the networks.
To quantify the average distance between the two genotype networks, we measured
the distance between every genotype on one network and the nearest genotype on the other
network (Fig. 2B). We find that this distance depends upon whether or not a lower bound
is set for genotypes to be considered a member of the genotype network. We find that the
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average distance between the networks decreases as the fitness cut-off is lowered (Fig. 2B).
For example, if “wild-type” activity is required (fitness > 1), the two networks are separated
by ~7 mutations on average. However, if molecules with 10% of wild-type activity or better
are considered part of the network, then most genotypes are only 1-2 mutations from the
other network.
Surprisingly, if we do not set any fitness cut-off, and count all genotypes as being
a part of a network as long as they were detected as catalytically active in all three replicates
of our assay, we find that over half the molecules (9,032) can actually perform both
functions (Fig 2C). Most of these dual-function intersection sequences have very low
fitness for both functions, and not surprisingly, no single sequence had higher than wildtype fitness for both functions (log10(fitness) > 0). However, several sequences do show
detectable levels of activity for one function and higher than wild-type fitness for the other
function. Under many evolutionary scenarios, these genotypes would be the most likely to
facilitate a molecular innovation because they would be favored if selection was acting on
only one function, yet would already provide the new function as a suboptimal
promiscuous function (23, 24). These results demonstrate that the genotype networks have
substantial overlap with numerous intersection sequences.
Next, we set out to evaluate the implications of these genotype networks for the
evolution of molecular innovations. The networks are in fact high-dimensional, which
limits any intuitive interpretation. We therefore turned to computational simulations of
populations of RNA molecules evolving on the networks. We modeled evolution using a
Wright-Fisher model (25) with a fixed population size, a fixed mutation rate, and selection
determined by the differences in the fitness of neighboring genotypes (see Supplementary

28
Materials). To simulate evolutionary innovations, we imagined the naturally occurring
HDV genotype as the established function and the in vitro selected Ligase activity as the
“new” function. We modeled a situation where the enzymatic function of the HDV
ribozyme is first under selection, but gene duplication allows a copy of the gene to evolve
under selection for Ligase activity. We therefore apply immediate selection pressure using
the Ligase fitness measurements, with no further consequence for the changes in HDV
activity. For these simulations, it is useful to think of the genotype networks as a threedimensional fitness landscape, where the height of the landscape is determined by the
fitness (Fig. 3A and Movie S1). Evolving populations will tend to move uphill towards the
peaks in such a landscape. We started multiple simulations from different genotypes on the
HDV network and challenged the populations to evolve on the Ligase fitness landscape.
We recorded these simulations as movies to observe the process of evolution toward the
new Ligase function (Fig. 3B and Movie S2-S5).
We noticed that many of the individual simulations had periods where the
population plateaus at a specific, often low average fitness for many generations (Fig. 3B).
To evaluate the average contribution of these periods of stasis, we measured the average
fitness of the evolving population over time (Fig. 4A and Fig. S1) and did so for 100
replicate simulations from each of the different starting genotypes (Fig. 4B). We find that
different genotypes on the HDV network result in different average rates of adaptation to
the new Ligase function (Fig. 4C). The fact that some genotypes promote very rapid
adaptation supports the idea that neutral evolution that enables a population to explore a
genotype network can facilitate evolutionary innovations (20, 26).
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Additionally, we find that there exist specific genotypes on the Ligase fitness
landscape that cause these periods of stasis and slower average rates of adaptation (Fig. 4D
and Fig. S2-S3). These genotypes are characterized by very few pathways to higher fitness.
Importantly, the genotypes that cause the slowest adaptation are characterized by extensive
reciprocal sign epistasis, meaning that achieving higher fitness requires two or more
mutational steps, but every initial step is deleterious. These genotypes are local fitness
peaks with not a single beneficial one-mutation-neighbor in our data set. Different starting
genotypes on the HDV network frequently stall at the same intermediate fitness level
indicating that they are likely to encounter a specific stasis genotype. These results are
encouraging for efforts aimed at forecasting evolutionary outcomes in cases where the
underlying fitness landscape can be measured or accurately estimated (27, 28).
Our results show that at regions of genotype space where two phenotypes
intersect, there exist numerous evolutionary trajectories between functions. We
demonstrate that this region enables rapid evolution of innovation. Mutational walks that
maintain one function while approaching a new function are abundant, and dual-function
sequences permeate this region of sequence space. The decrease in the fitness of both
functions at this interface suggests that intermediate forms are disfavored over the
sequences that can do one function well (10). The evolution of innovation in this
sequence space is not only possible, but probable. However, it remains unknown whether
these characteristics are peculiar to these specific phenotypes. Further research
advancements will be required to understand how functional intersections change over
larger expanses of genotype space, and if historic evolutionary innovations found in
natural systems have properties like the model system studied here. The high-probability
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of finding a dual0function sequence at this intersection encourages the search for more
genotype network intersections and motivates future research on the forecasting of
evolutionary innovations.
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Fig. 1 Evolutionary innovation from a network perspective. (A) Each node
represents a genotype. Genotypes with the same phenotype (genotype networks) have the
same color and are interconnected by mutational steps (edges). Gray nodes are nonfunctional. Proximal genotype networks have neighboring genotypes with different
phenotypes. Distant genotype networks have neighbors with the same function or that are
non-functional. (B) The two RNA phenotypes used in this study. Phenotypes are
represented by the structure diagram of the antigenomic HDV ribozyme (HDV phenotype)
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and the class III ligase ribozyme (Ligase phenotype). Each phenotype is detected by the
ability of a genotype to catalyze each specific chemical reaction that is shown beside each
structure, which results in the removal (HDV) or addition (Ligase) of a short sequence
(gray letters). The two structures have the same nucleotide sequence and nucleotides are
colored based on the secondary structure of the HDV phenotype. These sequence changes
following catalysis can be detected in nucleotide sequence data.

Fig. 2 The experimental fitness landscape at the intersection of two genotype
networks. (A) The overlay of the HDV and Ligase genotype networks. Nodes represent
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individual sequences, and sequences are connected by an edge if they are different by a
single nucleotide change. Nodes are colored based on their dominant activity (red = HDV;
blue = Ligase), and the fitness is indicated by the size of the node. Boxes on the left (HDV
reference) and right (Ligase reference) show the secondary structure for the reference
genotypes, and all the mutational changes that were analyzed. The mutations in blue boxes
convert the HDV reference to the Ligase reference. The mutations in red boxes convert the
Ligase reference to the HDV reference. Genotypes used to start evolutionary simulations
are indicated (a-p). Examples of stasis genotypes that were shown to impede evolution on
the Ligase fitness landscape are indicated (I-IV). (B) Distributions of shortest mutational
distance between genotypes on different networks as a function of fitness cut-off (blue =
Ligase to HDV distances; red = HDV to Ligase distances). Inset shows the distribution at
fitness cut-off = 1.3 as histograms; dashed lines indicate the sample means. The diagram
illustrates the measurement of distance between the two functions. (C) Intersection
sequences with detectable activity for both functions. Color indicates the ratio of ligation
fitness (blue) to HDV fitness (red).
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Fig. 3 Computational simulation of evolutionary innovation reveal periods of
stasis. (A) Three-dimensional fitness landscape for both genotype networks. The height of
each node indicates the relative fitness for the HDV phenotype (red) and the Ligase
phenotype (blue). Fitness are normalized so that both graphs are similar heights. Nodes are
connected if they are different at one nucleotide position. Starting genotypes (a,b,k,m) are
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indicated as examples that show different rates of Ligase adaptation. (B) Frames from
simulations of evolving populations. Genotypes present in the population (yellow nodes
and edges) change over generation time due to mutation and selection. The corresponding
mean fitness of these genotypes experience periods of stasis, followed by rapid increase in
fitness. During simulations the population size (N = 1000) and mutation rate (µ = 0.01)
were constant.
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Fig. 4 Starting genotypes result in different rates of adaptation. (A) Rates of
Ligase adaptation from a single HDV genotype. Each trace shows the average fitness as a
function of generation time for a separate simulation of 1000 individuals each. Inset shows
minor fluctuations during periods of stasis. Traces are colored from fastest (blue) to slowest
(red) (B) Average rates for multiple evolutionary simulations from different starting
genotypes. Each trace represents a different starting genotype and shows the mean fitness
of 100 simulations such as in (A) plotted as a function of generation time. (C) Distributions
of initial rates of adaptation and unique genotypes explored during simulations. Initial rate
is determined as the per generation fitness increase over the first 200 generations (see
Supplementary Materials). Unique genotypes represent the total number of genotypes
encountered during a simulation. (D) The local fitness landscape of genotypes that cause
periods of stasis show sign epistasis. The fitness of the stasis genotype is plotted at
mutations = 0 and marked with a dashed line. The fitness of neighboring genotypes that
differ by 1 or 2 mutations are shown. The roman numeral above each graph corresponds to
Fig. 2.

